| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4548 | S18327 | Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors |
|
| DCC4549 | S18616 Hydrochloride | Selective and highly potent alpha2-adrenoceptor agonist |
|
| DCC4550 | S1pr4-agonist-5c | Novel potent and selective agonist activity for S1PR4 |
|
| DCC4551 | S1r-in-10 | Novel selective sigma 1 receptor (S1R) antagonist, exhibiting potent binding affinity for S1R, high selectivity over S2R and 87 other human targets, acceptable in vitro metabolic stability, slowing clearance in liver microsomes, and excellent blood-brain |
|
| DCC4552 | S23515 Hydrochloride | Potent and selective ligand of imidazoline 1 receptor (I1R) |
|
| DCC4553 | S23757 | Potent and selective ligand of imidazoline 1 receptor (I1R) |
|
| DCC4554 | S27847 | Potent activator of the AMP-activated protein kinase (AMPK) |
|
| DCC4555 | S32797 | Potent quinone reductase 2 (QR2) inhibitor |
|
| DCC4556 | S-34324 | alpha2-Adrenoceptor Antagonist, Norepinephrine Transporter (NET) Inhibitor, Serotonine Transporter (SERT) Inhibitor |
|
| DCC4557 | s3i-201.1066 | Potent and selective inhibitor of constitutive Stat3 DNA-binding and transcriptional activities |
|
| DCC4558 | S3qel-1 | Novel modulator of the retrograde signaling including cellular responses to hypoxic and oxidative stress, selectively eliminating superoxide production by complex III without altering oxidative phosphorylation |
|
| DCC4559 | S-4048 | Potent inhibitor of glucose-6-phosphate translocase (G6P T1) |
|
| DCC4560 | S-49164 | Novel glucokinase (GK) activator |
|
| DCC4561 | S-50612 | Novel glucokinase (GK) activator |
|
| DCC4562 | S-73362 | Dual PPARα/γ agonist |
|
| DCC4563 | S8155-7 | Novel Analogue of SUN-B8155, acting as a cell active and functionally-relevant agonist of calcitonin receptor (CTR), inducing different Gs or arrestin activities through CTR |
|
| DCC4564 | S-8510 Phosphate | Partial benzodiazepine inverse agonist, showing antidepressant-like pharmacological activity and acting as a cognitive enhancer |
|
| DCC4565 | S-8921 | Novel ileal Na /bile acid cotransporter inhibitor |
|
| DCC4566 | Sab378 | Peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibiting gastrointestinal motility with no effect on experimental colitis in mice |
|
| DCC4567 | Safrazine Hydrochloride | Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI) |
|
| DCC4568 | Sag1.5 | Novel Smoothened receptor agonist |
|
| DCC4569 | Saha-bpyne | Novel clickable HDAC inhibitor, selectively labeling HDAC complex proteins |
|
| DCC4570 | Saha-obp | Novel Endogenous Reactive oxygen species (ROS)-activated HDAC inhibitor prodrug, demonstrating selective activity against multiple cancer cell lines such as HeLa, MCF-7, MDA-MB-231 and B16-F10, while remaining benign to non-cancer cells |
|
| DCC4571 | Salacinol | Natural α-glucosidase inhibitor |
|
| DCC4572 | Salazinic Acid | Natural α-glucosidase inhibitor, potently modulating Nrf 2 , NF-κB and STAT3 pathways |
|
| DCC4573 | Salbutamol | ß2-adrenoceptor agonist |
|
| DCC4574 | Salinomycin Sodium | Antibiotic, Inhibiting CD44 expression in breast cancer cells and mammary tumor growth |
|
| DCC4575 | Saliphe | Novel potent V-ATPase inhibitor, blocking viral entry |
|
| DCC4576 | Samidorphan L-malate | Opioid receptor antagonist for the treatment of alcoholism and cocaine addiction |
|
| DCC4577 | Sampangine | Natural antimicrobial and antitumor agent, inducing reactive oxygen species (ROS), and alterating heme biosynthesis |
|
